文献速递脑血管病外科神经重症

治疗性低温在出血性卒中患者中的效果与可行性:系统评价与Meta分析

Effect and Feasibility of Therapeutic Hypothermia in Patients with Hemorrhagic Stroke: A Systematic Review and Meta-Analysis.
PubMed 文献 · World Neurosurg · 2018-01-08

本系统评价与Meta分析纳入9项研究,比较治疗性低温与对照组在出血性卒中患者中的死亡、不良结局、迟发性脑缺血及特定并发症。总体分析显示两组死亡率(RR 0.78;95%CI 0.58-1.06;P=0.11)和不良结局率(RR 0.89;95%CI 0.70-1.12;P=0.32)无显著差异,但治疗性低温显著降低迟发性脑缺血(RR 0.61;95%CI 0.40-0.93;P=0.02),特定并发症发生率两组相当。

要点

  • 总体分析显示治疗性低温未显著降低死亡率(RR 0.78;95%CI 0.58-1.06;P=0.11)和不良结局率(RR 0.89;95%CI 0.70-1.12;P=0.32)。
  • 治疗性低温显著降低迟发性脑缺血(RR 0.61;95%CI 0.40-0.93;P=0.02)。
  • 随机研究亚组分析显示治疗性低温显著减少不良结局(RR 0.40;95%CI 0.22-0.74;P=0.003)。

核心结论

  • 总体效应显示治疗性低温未显著降低死亡率和不良结局,但降低了迟发性脑缺血的发病率。
  • 与对照组相比,治疗性低温的特定并发症发生率相当。

研究设计与样本

  • 基于系统评价与Meta分析首选报告条目(PRISMA)进行的系统评价,比较治疗性低温与对照组。
  • 共纳入9项研究,大多数为中等质量。

主要发现

  • 总体死亡率组间无显著差异(RR 0.78;95%CI 0.58-1.06;P=0.11)。
  • 总体不良结局率组间无显著差异(RR 0.89;95%CI 0.70-1.12;P=0.32)。
  • 剔除1项研究后的敏感性分析显示不良结局差异有统计学意义,支持治疗性低温。
  • 随机研究亚组分析显示治疗性低温显著减少不良结局(RR 0.40;95%CI 0.22-0.74;P=0.003)。
  • 治疗性低温较对照组显著降低迟发性脑缺血(RR 0.61;95%CI 0.40-0.93;P=0.02)。

关键数值与推荐

  • 亚组分析按研究类型、国家、平均年龄、出血类型、降温方法、治疗时长、复温速度和随访时间分层。
  • 主要比较指标为死亡率、不良结局、迟发性脑缺血和特定并发症。

局限性

  • 纳入研究大多数为中等质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Therapeutic hypothermia (TH) has shown good results in experimental models of hemorrhagic stroke. The clinical application of TH, however, remains controversial, since reports regarding its therapeutic effect are inconsistent. METHODS: We conducted a systematic review based on Preferred Reporting Items for Systematic Reviews and Meta-analyses comparing TH with a control group in terms of mortality, poor outcome, delayed cerebral ischemia (DCI), and specific complications. The subgroup analyses were stratified by study type, country, mean age, hemorrhage type, cooling method, treatment duration, rewarming velocity, and follow-up time. RESULTS: Nine studies were included, most of which were of moderate quality. The overall effect demonstrated insignificant differences in mortality (risk ratio [RR] 0.78; 95% confidence interval [CI] 0.58-1.06; P = 0.11) and poor outcome rate (RR 0.89; 95% CI 0.70-1.12; P = 0.32) between TH and the control group. However, sensitivity analyses, after we omitted 1 study, achieved a statistically significant difference in poor outcome favoring TH. Moreover, in the subgroup analyses, the results derived from randomized studies revealed that TH significantly reduced poor outcomes (RR 0.40; 95% CI 0.22-0.74; P = 0.003). In addition, TH significantly reduced DCI compared with control (RR 0.61; 95% CI 0.40-0.93; P = 0.02). The incidence of specific complications (rebleeding, pneumonia, sepsis, arrhythmia, and hydrocephalus) between the 2 groups were comparable and did not reach significant difference. CONCLUSIONS: The overall effect showed TH did not significantly reduce mortality and poor outcomes but led to a decreased incidence of DCI. Compared with control, TH resulted in comparable incidences of specific complications.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Yao Z, You C, He M, et al. Effect and Feasibility of Therapeutic Hypothermia in Patients with Hemorrhagic Stroke: A Systematic Review and Meta-Analysis. World Neurosurg. 2018. PMID: 29325957. doi:10.1016/j.wneu.2018.01.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。